170 related articles for article (PubMed ID: 6779387)
1. Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.
Ralph ED; Amatnieks YE
Sex Transm Dis; 1980; 7(4):157-60. PubMed ID: 6779387
[TBL] [Abstract][Full Text] [Related]
2. Comparative antimicrobial activity of metronidazole and the hydroxy metabolite against Gardnerella vaginalis.
Ralph ED
Scand J Infect Dis Suppl; 1983; 40():115-20. PubMed ID: 6607518
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis.
Easmon CS; Ison CA; Kaye CM; Timewell RM; Dawson SG
Br J Vener Dis; 1982 Aug; 58(4):246-9. PubMed ID: 6980684
[TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
Jones BM; Geary I; Alawattegama AB; Kinghorn GR; Duerden BI
J Antimicrob Chemother; 1985 Aug; 16(2):189-97. PubMed ID: 3905748
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Gardnerella vaginalis to metronidazole, its bioactive metabolites, and tinidazole.
Bannatyne RM; Jackowski J; Cheung R; Biers K
Am J Clin Pathol; 1987 May; 87(5):640-1. PubMed ID: 3495168
[TBL] [Abstract][Full Text] [Related]
6. Scanning electron microscopic examination of Bacteroides fragilis and Gardnerella vaginalis after exposure to concentration gradients of metronidazole and tinidazole.
Skarin A; MĂ„rdh PA
Scand J Infect Dis Suppl; 1981; 26():54-9. PubMed ID: 6972572
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Gardnerella vaginalis to thiamphenicol: clinical experience with nonspecific vaginitis.
Hubrechts JM; Vanhoof RL; Daems A; Butzler JP
Sex Transm Dis; 1984; 11(4 Suppl):456-9. PubMed ID: 6335301
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Haemophilus vaginalis (Corynebacterium vaginale) by metronidazole, tetracycline, and ampicillin.
Ralph ED; Austin TW; Pattison FL; Schieven BC
Sex Transm Dis; 1979; 6(3):199-202. PubMed ID: 388682
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
Weber P; Dubois S; Boussougant Y
J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of Haemophilus vaginalis (Corynebacterium vaginale) to oleandomycin and spectinomycin.
Virtanen S
Pathol Microbiol (Basel); 1975; 42(1):36-41. PubMed ID: 125402
[TBL] [Abstract][Full Text] [Related]
11. Metronidazole in treatment against Haemophilus vaginalis (Corynebacterium vaginale).
Ralph ED; Amatnieks YE
Antimicrob Agents Chemother; 1980 Jul; 18(1):101-4. PubMed ID: 6968175
[TBL] [Abstract][Full Text] [Related]
12. Metronidazole metabolite and Gardnerella vaginalis (Corynebacterium vaginale).
Baldson MJ; Jackson D
Lancet; 1981 May; 1(8229):1112. PubMed ID: 6112482
[No Abstract] [Full Text] [Related]
13. In vitro susceptibility of Gardnerella vaginalis and Bacteroides organisms, associated with nonspecific vaginitis, to sulfonamide preparations.
Jones BM; Kinghorn GR; Geary I
Antimicrob Agents Chemother; 1982 Jun; 21(6):870-2. PubMed ID: 6981374
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of 5 new quinolones against Gardnerella vaginalis].
Lefevre JC; Gaubert E; Lareng MB
Pathol Biol (Paris); 1989 May; 37(5):394-6. PubMed ID: 2550875
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp.
Pendland SL; Piscitelli SC; Schreckenberger PC; Danziger LH
Antimicrob Agents Chemother; 1994 Sep; 38(9):2106-10. PubMed ID: 7811027
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of Gardnerella vaginalis to metabolites of metronidazole and tinidazole.
Shanker S; Munro R
Lancet; 1982 Jan; 1(8264):167. PubMed ID: 6119542
[No Abstract] [Full Text] [Related]
17. [Sensitivity of Gardnerella vaginalis to antibiotics. Study of 40 strains isolated at the Purpan University Hospital Center of Toulouse].
Lefevre JC; Prere MF; Lareng MB
Pathol Biol (Paris); 1983 Jun; 31(6):533-5. PubMed ID: 6348664
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis.
Mohanty KC; Deighton R
J Antimicrob Chemother; 1987 Mar; 19(3):393-9. PubMed ID: 3494725
[TBL] [Abstract][Full Text] [Related]
19. Activity of ciprofloxacin against genital tract pathogens.
Hart CA; How SJ; Hobson D
Br J Vener Dis; 1984 Oct; 60(5):316-8. PubMed ID: 6435814
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the Gardnerella vaginalis syndrome. A controlled, double-blind study comparing pivampicillin and metronidazole.
Hansen JG; Schmidt H
Scand J Prim Health Care; 1985 Sep; 3(3):151-4. PubMed ID: 3903906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]